Abstract
Organ transplantation is an effective life-sparing modality for thousands of patients with organ failure syndromes. In spite of important advances in surgical technique and immunosuppressive regimens that have made organ transplantation a safer procedure today when compared to previous decades, there remain substantial risks of infection and other complications related to these procedures. Among the infectious complications of organ transplantation, none is associated with a greater impact on morbidity and mortality than invasive fungal infections (IFI) [1–5]. Fungal infections in organ transplant recipients (OTRs) vary in frequency, etiology, and pathogenesis according to the type of organ transplant procedure. Variations in immunosuppressive regimens, surgical technique, infection control, and exposure history further complicate evaluation of these patients. Moreover, the incidence of IFIs among this group of patients varies considerably from center to center [6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis. 1993;16:677–88.
Hibberd PL, Rubin RH. Clinic aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994;19 Suppl 1:33–40.
Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin N Am. 1995;9:1045–74.
Dictar MO, Maiolo E, Alexander B, Jacob N, Veron MT. Mycoses in the transplanted patient. Med Mycol. 2000;38:251–8.
Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45:305–20.
Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101–12.
Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, editors. Clinical approach to infections in the compromised host. 3rd ed. New York: Plenum; 1994. p. 629–705.
Fishman JA. Infection in solid-organ transplant recipients. N Eng J Med. 2007;357:2601–14.
Patel R, Paya CV. Infections in solid organ transplant recipients. Clin Microbiol Rev. 1997;10:86–124.
Patel R. Infections in recipients of kidney transplants. Infect Dis Clin N Am. 2001;15:901–51.
Abbott KC, Hypolite I, Poropatich RK, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis. 2001;3:203–11.
Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin N Am. 2003;17:113–34.
Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49:710–6.
Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch Intern Med. 1983;143:703–7.
Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann NY Acad Sci. 2007;1111:365–76.
Heinz T, Perfect J, Schell W, Ditter E, Ruff G, Serafin D. Soft tissue fungal infections: surgical management of 12 immunocompromised patients. Plast Reconstr Surg. 1996;97:1391–9.
Chkhotua A, Yussim A, Tovar A, et al. Mucormycosis of the renal allograft: case report and review of the literature. Transpl Int. 2001;14:438–41.
Lussier N, Laverdiere M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis. 2000;31:1299–301.
Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467–76.
Nampoory MR, Khan ZU, Johny KV, et al. Invasive fungal infections in renal transplant recipients. J Infect. 1996;33:95–101.
Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore). 1999;78:123–38.
Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44–69.
Patterson JE, Peters J, Calhoon JH, et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2000;2:22–8.
Carlini A, Angelini D, Burrows L, DeQuirico G, Antonelli A. Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant. Nephrol Dial Transplant. 1998;13:2659–61.
Garcia A, Mazuecos A, Flayo A, et al. Isolated cerebral aspergillosis without a portal of entry-complete recovery after liposomal amphotericin B and surgical treatment. Nephrol Dial Transplant. 1998;9:2385–7.
Marin P, Garcia-Martos P, Carcia-Doncel A, et al. Endocarditis by Aspergillus fumigatus in a renal transplant. Mycopathologia. 1999;145:127–9.
Viertel A, Ditting T, Pistorius K, Geiger H, Scheuermann EH. Just-Nubling G. An unusual case of Aspergillus endocarditis in a kidney transplant recipient. Transplantation. 1999;68:1812–3.
Kim SW, Nah MY, Ueum CH, et al. Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect. 2001;42:215–7.
Shirwany A, Sargent SJ, Dmochowski RR, Bronze MS. Urinary tract aspergillosis in a renal transplant recipient. Clin Infect Dis. 1998;27:1336.
Kaplan-Pavlovcic S, Masera A, Ovcak Z, Kmetec A. Prostatic aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999;14:1778–80.
Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7:1–14.
Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis. 2008;47:1321–7.
Lumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis. 1995;20:514–20.
Benedetti E, Gruessner AC, Troppmann C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg. 1996;183:307–16.
Smets YF, van der Piji JW, van Dissel JT, Ringers FJ, de Fijter JW, Lemkes HH. Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant. 1997;12:764–71.
Hesse UJ, Sutherland DER, Najarian JS, Simmons RL. Intra-abdominal infections in pancreas transplant recipients. Ann Surg. 1986;203:153–62.
Pirsch JD, Odorico JS, D’Alessandro AM, Knechtle SJ, Becker BN, Sollinger HW. Post-transplant infections in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation. 1998;66:1746–50.
Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation. 1985;40:347–53.
Singh N, Pruett TL, Houston S, et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl. 2006;12:1205–9.
Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36:46–52.
Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation. 2003;75:2023–9.
Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21:534–46.
Sun HY, Singh N. Emerging importance of infections due to zygomycetes in organ transplant recipients. Int J Antimicrob Agents. 2008;32 Suppl 2:S115–8.
Sun HY, Aguado JM, Bonatti H, et al. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009;9:2166–71.
Davis JA, Horn DL, Marr KA, Fishman JA. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Transpl Infect Dis. 2009;11:432–7.
Sun HY, Wagener MM, Singh N. Cryptococcosis in solid-organ, hemtopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis. 2009;48:1566–76.
Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994;170:644–52.
Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida or non-Candida fungal infections after liver transplantation. Transplantation. 1996;62:926–34.
Singh N, Aguado JM, Bonatti H, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002–11.
Waser M, Maggiorini M, Luthy A, et al. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis. 1994;13:12–8.
Kramer MR, Marshal SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation analysis of 200 episodes. Arch Intern Med. 1993;153:2010–6.
Grossi P, Glaudio F, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients. Transplantation. 2000;70:112–6.
Goldstein DJ, El-Amir NG, Ashton RC, et al. Fungal infections in left ventricular assist device recipients: incidence, prophylaxis, and treatment. ASAIO J. 1995;41:873–5.
Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997;16:822–31.
Gordon SM, Avery RK. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis. 2001;3:161–7.
Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 2003;22:258–66.
Mehrad B, Giusppe P, Martinez FJ, Clark T, Iannettoni MD, Lynch JP. Spectrum of Aspergillus infection in lung transplant recipients. Chest. 2001;119:169–75.
Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant. 1995;14:883–90.
Westney GE, Kesten S, de Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation. 1996;61:915–9.
Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest. 1997;112:1160–4.
Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998;26:753–5.
Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation. 2001;71:242–6.
Marks WH, Florence L, Lieberman J, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996;61:1771–83.
Nunley DR, Ohori NP, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest. 1998;114:1321–9.
Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance to Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2000;19:53–6.
Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.
Dauber HJ, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med. 1990;11:291–308.
Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart transplant recipients: report of 9 cases and review of the literature. Medicine (Baltimore). 1996;75:142–56.
Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17:770–82.
Reyes J, Abu-Elmagd K, Tzakis A, et al. Infectious complications after human small bowel transplantation. Transplantation. 1992;24:1249–50.
Kusne S, Furukawa H, Abu-Elmagd K, et al. Infectious complications after small bowel transplantation in adults: an update. Transplant Proc. 1996;28:2761–2.
Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis. 2005;7:109–15.
Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant. 1996;10:160–5.
Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369–74.
Singh N, Limaye AP, Forrest G, et al. Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol. 2006;44:445–9.
Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48:772–86.
The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppresion in liver transplantation. N Engl J Med. 1994;331:1110–5.
Bernabeu-Wittel M, Naranjo M, Cisneros JM, et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. Eur J Clin Microbiol Infect Dis. 2002;21:173–80.
Kontoyiannis DP, Lewis RE, Alexander BD, et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008;52:735–8.
Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis. 1992;14:232–4.
Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med. 2000;343:1163–6.
Wright P, Pappagianis D, Davis CA, et al. Transmission of Coccidioides immitis from donor organs: a description of two fatal cases of disseminated coccidioidomycosis. Clin Infect Dis. 2003;37:1265–9.
Brugière O, Forget E, Biondi G, et al. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation. 2009;88:1319–20.
Tripathy U, Yung GL, Kriett JM, Thistlewaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thoracic Surg. 2002;73:306–8.
Battaglia M, Ditonno P, Fiore T, De Ceglie G, Regina G, Selvaggi FP. True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor. J Urol. 2000;163:1236–7.
Albano L, Bretagne S, Mamzer-Bruneel MF, et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis. 2009;48:194–202.
Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109:1119–24.
Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005;40:1413–21.
Gallis HA, Berman RA, Cate TR, Hamilton JD, Gunnels JC, Stickel DL. Fungal infections following renal transplantation. Arch Intern Med. 1975;135:1163–72.
Ciancio G, Burke GW, Viciana AL, et al. Destructive allograft fungal arteritis following simultaneous pancreas-kidney transplantation. Transplantation. 1996;61:1172–5.
Potti A, Danielson B, Sen K. “True” mycotic aneurysm of a renal artery allograft. Am J Kidney Dis. 1998;31:E3.
Dowling RD, Baladi N, Zenati M, et al. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thoracic Surg. 1990;49:118–22.
Ralph ED, Hussain Z. Chronic meningitis caused by Candida albicans in a liver transplant recipient: usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment. Clin Infect Dis. 1996;23:191–2.
Choi IS, Kim SJ, Kim BY, et al. Candida polyarthritis in a renal transplant patient: case report of a patient successfully treated with amphotericin B. Transplant Proc. 2000;32:1963–4.
Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47:3138–41.
Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis: disease spectrum, treatment, practice, and outcomes. Medicine (Baltimore). 2000;79:250–60.
Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systemic review of the literature. Clin Infect Dis. 2001;32:658–66.
Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis. 1991;144:552–8.
Sayiner A, Kursat S, Toz H, Duman S, Onal B, Tumbay E. Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999;14:1784–5.
Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996;100:171–8.
Brown RS, Lake JR, Katzman BA, et al. Incidence of significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996;61:666–9.
Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824–33.
Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 2007;83:1330–6.
Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis. 1999;1:229–36.
Kapoor A, Flechner SM, O’Malley K, Paolone D, File TM, Cutrona AF. Cryptococcal meningitis in renal transplant patients associated with environmental exposure. Transplant Infect Dis. 1999;1:213–7.
Hunger RE, Paredes BE, Quattroppani C, Krahenbuhl S, Braathen LR. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology. 2000;200:352–5.
Nosanchuk JD, Shoham S, Fries BC, Shapiro S, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000;132:205–8.
Anderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis. 1992;14:666–72.
Baer S, Baddley JW, Gnann JW, Pappas PG. Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients. Transpl Infect Dis. 2009;11:353–8.
Chandesris LF, MO PS, et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant. 2007;7:2826–8.
Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33:690–9.
Singh N, Alexander BD, Lortholary O, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis. 2007;195:756–64.
Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395–401.
Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis. 2005;40:1756–61.
Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation. 2005;80:1131–3.
Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation. 2008;86:647–51.
Demirag A, Elkhammas EA, Henry ML, et al. Pulmonary Rhizopus infection in a diabetic renal transplant recipient. Clin Transplant. 2000;14:8–10.
Lee E, Vershvovsky Y, Miller F, Waltzer W, Suh H, Nord EP. Combined medical surgical therapy for pulmonary mucormycosis in a diabetic renal allograft recipient. Am J Kidney Dis. 2001;38:E37.
Jimenez C, Lumbreras C, Aguado JM, et al. Successful treatment of Mucor infection after liver or pancreas-kidney transplantation. Transplant. 2002;73:476–80.
Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Review. Am J Clin Pathol. 1992;98:559–64.
Sheu BS, Lee PC, Yang HB. A giant gastric ulcer caused by mucormycosis infection in a patient with renal transplantation. Endoscopy. 1998;30:S60–1.
Ju JH, Park HS, Shin MJ, et al. Successful treatment of massive lower gastrointestinal bleeding caused by mixed infection of cytomegalovirus and mucormycosis in a renal transplant recipient. Am J Nephrol. 2001;21:232–6.
Timmouth J, Baker J, Gardiner G. Gastrointestinal mucormycosis in a renal transplant patient. Can J Gastroenterol. 2001;15:269–71.
Gold WL, Vellend H, Salit IE, et al. Successful treatment of systemic and local infections due to Exophiala spp. Clin Infect Dis. 1994;19:339–41.
Salama AD, Rogers T, Lord GM, Lechler RI, Mason PD. Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcome. Transplantation. 1997;63:160–2.
von Eiff C, Bettin D, Proctor RA, et al. Phaeocremonium parasiticum infective endocarditis following liver transplantation. Clin Infect Dis. 1997;25:1251–3.
Mesa A, Henao J, Gil M, Durango G. Phaeohyphomycosis in kidney transplant patients. Clin Transplant. 1999;13:273–6.
Malani PN, Bleicher JJ, Kauffman CA, Davenport DS. Disseminated Dactylaria constricta infection in a renal transplant recipient. Transpl Infect Dis. 2001;3:40–3.
Castro LG, da Silva Lacaz C, Guarro J, et al. Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol. 2001;39:2321–4.
Magina S, Libosa C, Santos P, et al. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient. Br J Dermatol. 2000;142:1261–2.
Halaby T, Boots H, Vermeulen A, et al. Phaeohyphomycosis caused by Alternaria infectoria in a renal transplant recipient. J Clin Microbiol. 2001;39:1952–5.
Blair JE. Coccidioidomycosis in liver transplantation. Liver Transplant. 2006;12:31–9.
Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536–44.
Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6:340–5.
Marques SA, Hozumi S, Camargo RM, Carvalho MF, Marques ME. Histoplasmosis presenting as cellulitis 18 years after renal transplantation. Med Mycol. 2008;46:725–8.
McGuinn ML, Lawrence ME, Proia L, Segreti J. Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. Transplant Proc. 2005;37:4313–4.
Bacal F, Andrade AC, Migueletto BC, et al. Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas’ disease. Arquivos Brasileiors de Cardiologia. 2001;76:403–8.
Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis. 1999;18:662–4.
Livas IC, Nechay PS, Nauseef WM. Clinical evidence of spinal and cerebral histoplasmosis twenty years after renal transplantation. Clin Infect Dis. 1995;20:692–5.
Zainudin BM, Kassim F, Annuar NM, Lim CS, Ghazali AK, Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hygiene. 1992;95:276–9.
Brett MT, Kwan JT, Bending MR. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol. 1988;41:992–5.
Cohen IM, Galgini JN, Potter D, Ogden DA. Coccidioidomycosis in renal transplant replacement therapy. Arch Intern Med. 1982;142:489–94.
Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993;16:54–8.
Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310–7.
Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore). 1994;72:311–25.
Agarwal SK, Tiwari SC, Dash SC, et al. Urinary sporotrichosis in a renal allograft recipient. Nephron. 1994;66:485.
Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987;9:369–75.
Guarro J, Nucci M, Akiti T, Gene J, Barreiro MD, Goncalves RT. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J Clin Microbiol. 2000;38:419–21.
Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis. 2001;32:1237–40.
Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008.
Clark NM. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis. 1999;28:1169–70.
Blackwell W, Ahmed K, O’Docherty C, Hay RJ. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient. Br J Dermatol. 2000;143:873–5.
Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis. 2000;32:331–2.
Guarro J, Antolin Ayala MI, Gene J, Gutierrez-Calzada J, Nieves-Diez C, Ortoneda M. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol. 1999;37:3751–5.
Gordon SM, LaRosa SP, Kalmadi S, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis. 1999;28:240–6.
Torre-Cisneros J, De la Mata M, Pozo JC, et al. Randomized trial of weekly sulfadoxine/pyrimethamine versus daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Clin Infect Dis. 1999;29:771–4.
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of the EORTC/MSG Consensus Group for invasive fungal diseases. Clin Infect Dis. 2008;46:1813–21.
Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1,3) β-D glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654–9.
Husain S, Kwak EJ, Obman A, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant. 2004;4:796–802.
Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:729–37.
Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. Transplantation. 1995;59:45–50.
Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006;6:386–91.
Hadley S, Huckabee C, Pappas PG, et al. Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis. 2009;11:40–8.
Marty FM, Rubin RH. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int. 2006;19:2–11.
Palmer SM, Drew RH, Whitehouse JD, et al. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation. 2001;72:545–8.
Monforte V, Roman A, Gavalda J, et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant. 2001;20:1274–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pappas, P.G. (2011). Fungal Infections in Solid Organ Transplant Recipients. In: Kauffman, C., Pappas, P., Sobel, J., Dismukes, W. (eds) Essentials of Clinical Mycology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6640-7_30
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6640-7_30
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6639-1
Online ISBN: 978-1-4419-6640-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)